Kistler Tiffany Companies, LLC Bristol Myers Squibb CO Transaction History

Kistler Tiffany Companies, LLC

$615 Million
Q2 2023

A detailed history of Kistler Tiffany Companies, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kistler Tiffany Companies, LLC holds 12,863 shares of BMY stock, worth $742,966. This represents 0.13% of its overall portfolio holdings.

Number of Shares

12,863

Previous 12,315 4.45%

Holding current value

$742,966

Previous $853,000 3.63%

% of portfolio

0.13%

Previous 0.16%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	BUY	$63.71 - $70.74 $34,913 - $38,765	548 Added 4.45%	12,863 $822,000
Q1 2023 May 03, 2023	BUY	$65.71 - $74.53 $1,117 - $1,267	17 Added 0.14%	12,315 $853,000
Q4 2022 Jan 27, 2023	SELL	$68.48 - $81.09 $3,971 - $4,703	-58 Reduced 0.47%	12,298 $884,000
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $57 - $33,886	-441 Reduced 3.45%	12,356 $878,000
Q2 2022 Aug 08, 2022	BUY	$72.62 - $79.98 $1,379 - $1,519	19 Added 0.15%	12,797 $985,000
Q1 2022 May 11, 2022	SELL	$61.48 - $73.72 $46,601 - $55,879	-758 Reduced 5.6%	12,778 $933,000
Q4 2021 Jan 25, 2022	SELL	$53.63 - $62.52 $179,767 - $209,567	-3,352 Reduced 19.85%	13,536 $844,000
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $55,383 - $64,874	-936 Reduced 5.25%	16,888 $999,000
Q2 2021 Aug 04, 2021	BUY	$61.91 - $67.42 $309 - $337	5 Added 0.03%	17,824 $1.19 Million
Q1 2021 May 07, 2021	BUY	$59.34 - $66.74 $76,785 - $86,361	1,294 Added 7.83%	17,819 $1.13 Million
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $35,163 - $39,846	609 Added 3.83%	16,525 $1.03 Million
Q3 2020 Nov 03, 2020	SELL	$57.43 - $63.64 $109,921 - $121,806	-1,914 Reduced 10.73%	15,916 $960,000
Q2 2020 Jul 20, 2020	BUY	$54.82 - $64.09 $179,151 - $209,446	3,268 Added 22.44%	17,830 $1.05 Million
Q4 2019 Jan 14, 2020	BUY	$49.21 - $64.19 $136,114 - $177,549	2,766 Added 23.45%	14,562 $935,000
Q3 2019 Oct 18, 2019	BUY	$42.77 - $50.71 $25,234 - $29,918	590 Added 5.27%	11,796 $598,000
Q2 2019 Jul 22, 2019	SELL	$44.62 - $49.34 $37,703 - $41,692	-845 Reduced 7.01%	11,206 $508,000
Q1 2019 Apr 16, 2019	BUY	$45.12 - $53.8 $26,350 - $31,419	584 Added 5.09%	12,051 $575,000
Q4 2018 Jan 14, 2019	SELL	$48.76 - $63.23 $59,487 - $77,140	-1,220 Reduced 9.62%	11,467 $596,000
Q3 2018 Oct 19, 2018	SELL	$55.19 - $62.25 $21,744 - $24,526	-394 Reduced 3.01%	12,687 $788,000
Q2 2018 Jul 17, 2018	SELL	$50.53 - $62.98 $82,313 - $102,594	-1,629 Reduced 11.07%	13,081 $724,000
Q1 2018 Apr 06, 2018	SELL	$59.92 - $68.98 $41,464 - $47,734	-692 Reduced 4.49%	14,710 $930,000
Q4 2017 Jan 11, 2018	BUY	$59.94 - $65.35 $10,309 - $11,240	172 Added 1.13%	15,402 $944,000
Q3 2017 Oct 19, 2017	BUY	$55.23 - $63.74 $841,152 - $970,760	15,230	15,230 $971,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kistler Tiffany Companies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kistler Tiffany Companies, LLC with notifications on news.

Account

Kistler Tiffany Companies, LLC Bristol Myers Squibb CO Transaction History